INSC

gene
On this page

Summary

INSC (INSC spindle orientation adaptor protein, HGNC:33116) is a protein-coding gene on chromosome 11p15.2, encoding Protein inscuteable homolog (Q1MX18). May function as an adapter linking the Par3 complex to the GPSM1/GPSM2 complex.

In Drosophila, neuroblasts divide asymmetrically into another neuroblast at the apical side and a smaller ganglion mother cell on the basal side. Cell polarization is precisely regulated by 2 apically localized multiprotein signaling complexes that are tethered by Inscuteable, which regulates their apical localization (Izaki et al., 2006 [PubMed 16458856]).

Source: NCBI Gene 387755 — RefSeq curated summary.

At a glance

  • GWAS associations: 9
  • Clinical variants (ClinVar): 121 total
  • MANE Select transcript: NM_001042536

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33116
Approved symbolINSC
NameINSC spindle orientation adaptor protein
Location11p15.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000188487
Ensembl biotypeprotein_coding
OMIM610668
Entrez387755

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 12 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000379554, ENST00000379556, ENST00000424273, ENST00000447214, ENST00000525218, ENST00000526102, ENST00000528567, ENST00000530161, ENST00000876188, ENST00000876189, ENST00000876190, ENST00000876191, ENST00000961585, ENST00000961586

RefSeq mRNA: 6 — MANE Select: NM_001042536 NM_001031853, NM_001042536, NM_001278313, NM_001278314, NM_001278315, NM_001278316

CCDS: CCDS41621, CCDS41622, CCDS60735, CCDS60736

Canonical transcript exons

ENST00000379556 — 13 exons

ExonStartEnd
ENSE000013793651517711115177163
ENSE000013831981517832415178447
ENSE000015380751511492315115003
ENSE000015995111517574115176086
ENSE000021840571524591215247208
ENSE000026870781520082415200949
ENSE000034584441523891915239074
ENSE000034956071523560215235668
ENSE000034974221519070115190814
ENSE000035099451524044715240523
ENSE000035295911522147715221648
ENSE000035810281522565015225828
ENSE000036498081514913015149230

Expression profiles

Bgee: expression breadth ubiquitous, 158 present calls, max score 89.71.

FANTOM5 (CAGE): breadth broad, TPM avg 1.9315 / max 151.2291, expressed in 240 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1132311.6337224
1132320.226584
2061980.07132

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibiaUBERON:000097989.71gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.77gold quality
secondary oocyteCL:000065586.51gold quality
dorsal root ganglionUBERON:000004485.10gold quality
oocyteCL:000002385.08gold quality
tibial nerveUBERON:000132383.40gold quality
trigeminal ganglionUBERON:000167583.23gold quality
sural nerveUBERON:001548880.26gold quality
mucosa of transverse colonUBERON:000499176.64gold quality
muscle layer of sigmoid colonUBERON:003580576.11gold quality
buccal mucosa cellCL:000233676.07gold quality
cartilage tissueUBERON:000241873.67silver quality
transverse colonUBERON:000115772.21gold quality
trabecular bone tissueUBERON:000248371.85silver quality
colonUBERON:000115571.52gold quality
small intestine Peyer’s patchUBERON:000345471.26gold quality
lower esophagus muscularis layerUBERON:003583371.05gold quality
lower esophagusUBERON:001347370.98gold quality
large intestineUBERON:000005970.52gold quality
intestineUBERON:000016070.22gold quality
esophagogastric junction muscularis propriaUBERON:003584170.10gold quality
small intestineUBERON:000210869.95gold quality
rectumUBERON:000105268.92gold quality
body of stomachUBERON:000116166.07gold quality
right atrium auricular regionUBERON:000663165.16gold quality
popliteal arteryUBERON:000225064.82gold quality
tibial arteryUBERON:000761064.77gold quality
stomachUBERON:000094564.32gold quality
cardiac atriumUBERON:000208164.18gold quality
vermiform appendixUBERON:000115463.88gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.57

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

49 targeting INSC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-656-3P100.0072.152788
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-4455100.0065.481587
HSA-MIR-4481100.0066.421669
HSA-MIR-3689D100.0066.141181
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-56899.9869.862084
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-365899.9673.874379
HSA-MIR-570-3P99.9672.414910
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-448799.9664.581252
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-130599.9171.433443
HSA-MIR-129799.9173.413162
HSA-MIR-568099.9169.833421
HSA-MIR-612499.8769.783551
HSA-MIR-5003-3P99.8569.292517
HSA-MIR-4760-5P99.8069.881619
HSA-MIR-498-5P99.7669.641807
HSA-MIR-494-3P99.7071.452795
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-472999.6972.184233
HSA-MIR-561-3P99.6470.903647
HSA-MIR-806199.6369.441411
HSA-MIR-6716-5P99.5668.621244
HSA-MIR-510-3P99.5470.062965
HSA-MIR-451999.4866.10859
HSA-MIR-608399.4768.732393

Literature-anchored findings (GeneRIF, showing 7)

  • cloning of two distinct cDNAs from Insc gene, which is differentially expressed from alternative first exons;Insc proteins bind to the Pins homologues LGN and AGS3, and also to Par3 and Par3beta (PMID:16458856)
  • These data present AGS3, G-proteins, and mInsc as candidate proteins involved in regulating cellular stress associated with protein-processing pathologies. (PMID:20065032)
  • mInsc-LGN interaction is vital for stabilization of LGN and for intracellular localization of mInsc. (PMID:22074847)
  • Studies indicate that the Inscuteable (Insc)and NuMA are mutually exclusive interactors of LGN. (PMID:22977735)
  • In mammary stem cells, the asymmetric domain of Insc bound to LGN:Galphai(GDP) suffices to drive asymmetric fate, and reverts aberrant symmetric divisions induced by p53 loss. (PMID:29523789)
  • Genome-wide association study identified INSC gene associated with Trail Making Test Part A and Alzheimer’s disease related cognitive phenotypes. (PMID:34224794)
  • A missense mutation in human INSC causes peripheral neuropathy. (PMID:38589651)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusInscENSMUSG00000048782
rattus_norvegicusInscENSRNOG00000024712
drosophila_melanogasterinscFBGN0011674
caenorhabditis_elegansWBGENE00018392

Protein

Protein identifiers

Protein inscuteable homologQ1MX18 (reviewed: Q1MX18)

All UniProt accessions (2): A0A0A0MSI1, Q1MX18

UniProt curated annotations — full annotation on UniProt →

Function. May function as an adapter linking the Par3 complex to the GPSM1/GPSM2 complex. Involved in spindle orientation during mitosis. May regulate cell proliferation and differentiation in the developing nervous system. May play a role in the asymmetric division of fibroblasts and participate in the process of stratification of the squamous epithelium.

Subunit / interactions. Interacts with ALS2CR19/PAR3B and F2RL2/PAR3. Interacts with GPSM1/AGS3 and GPSM2/LGN (via TPR repeat region). Identified in a complex with GPSM2 and F2RL2.

Subcellular location. Cytoplasm. Cell cortex.

Tissue specificity. Isoform 1 is expressed in various tissues with stronger expression in liver, kidney and small intestine. Isoform 2 is abundantly expressed in small intestine and to a lower extent in lung and pancreas.

Isoforms (6)

UniProt IDNamesCanonical?
Q1MX18-11, Longyes
Q1MX18-22, Short
Q1MX18-33
Q1MX18-44
Q1MX18-55
Q1MX18-66

RefSeq proteins (6): NP_001027024, NP_001036001, NP_001265242, NP_001265243, NP_001265244, NP_001265245 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000225ArmadilloRepeat
IPR011989ARM-likeHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR031938INSC_LBDDomain
IPR038205INSC_LBD_sfHomologous_superfamily
IPR039921InscuteableFamily
IPR045789Insc_CDomain

Pfam: PF16748, PF19427

UniProt features (24 total): sequence conflict 6, splice variant 6, mutagenesis site 3, sequence variant 2, helix 2, strand 2, chain 1, region of interest 1, short sequence motif 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
3SF4X-RAY DIFFRACTION2.6

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q1MX18-F183.440.70

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Mutagenesis-validated functional residues (3):

PositionPhenotype
78abolishes interaction with gpsm2.
89strongly reduces interaction with gpsm2. abolishes interaction with gpsm2 and gpsm1; when associated with d-97.
97abolishes interaction with gpsm2 and gpsm1; when associated with r-89.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 51 (showing top): GOBP_APICAL_PROTEIN_LOCALIZATION, GOBP_ASYMMETRIC_CELL_DIVISION, GOBP_REGULATION_OF_CELL_DIVISION, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOCC_CYTOPLASMIC_REGION, GOCC_APICAL_PART_OF_CELL, GOCC_CELL_CORTEX_REGION, GOBP_CELL_DIVISION, GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY, BOCHKIS_FOXA2_TARGETS, OHGUCHI_LIVER_HNF4A_TARGETS_DN, GOCC_APICAL_CORTEX, GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN, PAX3_TARGET_GENES, MIR3658

GO Biological Process (6): nervous system development (GO:0007399), asymmetric cell division (GO:0008356), regulation of asymmetric cell division (GO:0009786), cell differentiation (GO:0030154), regulation of protein stability (GO:0031647), apical protein localization (GO:0045176)

GO Molecular Function (4): cytoskeletal adaptor activity (GO:0008093), protein domain specific binding (GO:0019904), protein-macromolecule adaptor activity (GO:0030674), protein binding (GO:0005515)

GO Cellular Component (5): plasma membrane (GO:0005886), protein-containing complex (GO:0032991), apical cortex (GO:0045179), cytoplasm (GO:0005737), cell cortex (GO:0005938)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein binding2
cell periphery2
system development1
cell division1
asymmetric cell division1
regulation of cell division1
cellular developmental process1
regulation of biological quality1
intracellular protein localization1
cytoskeletal protein binding1
protein-macromolecule adaptor activity1
molecular adaptor activity1
binding1
membrane1
cellular_component1
cell cortex region1
intracellular anatomical structure1
cellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

790 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
INSCGPSM2P81274853
INSCPARD3BQ8TEW8831
INSCPARD3Q8TEW0620
INSCLGALS4P56470598
INSCGPSM1Q86YR5583
INSCNUMA1Q14980518
INSCTHP07101471
INSCNUMBLQ9Y6R0450
INSCNUMBP49757447
INSCNESP48681435
INSCPOU3F4P49335434
INSCPAX6P26367426
INSCSOX2P48431417
INSCPRR12Q9ULL5412
INSCSCAF1Q9H7N4382

IntAct

43 interactions, top by confidence:

ABTypeScore
GPSM2INSCpsi-mi:“MI:0915”(physical association)0.670
INSCTTC23psi-mi:“MI:0915”(physical association)0.560
INSCUSP54psi-mi:“MI:0915”(physical association)0.560
INSCLHX3psi-mi:“MI:0915”(physical association)0.560
SORBS3INSCpsi-mi:“MI:0915”(physical association)0.560
INSCRUSC1psi-mi:“MI:0915”(physical association)0.560
INSCMGC50722psi-mi:“MI:0915”(physical association)0.560
INSCTEKT3psi-mi:“MI:0915”(physical association)0.560
GEMINSCpsi-mi:“MI:0915”(physical association)0.560
PRR35INSCpsi-mi:“MI:0915”(physical association)0.560
GPANK1INSCpsi-mi:“MI:0915”(physical association)0.560
INSCZNF587psi-mi:“MI:0915”(physical association)0.560
INSCSMARCD1psi-mi:“MI:0915”(physical association)0.560
INSCA2ML1psi-mi:“MI:0914”(association)0.350
INSCGPSM2psi-mi:“MI:0915”(physical association)0.000
INSCUSP54psi-mi:“MI:0915”(physical association)0.000
INSCSORBS3psi-mi:“MI:0915”(physical association)0.000
INSCLHX3psi-mi:“MI:0915”(physical association)0.000
INSCRUSC1psi-mi:“MI:0915”(physical association)0.000
MGC50722INSCpsi-mi:“MI:0915”(physical association)0.000
TEKT3INSCpsi-mi:“MI:0915”(physical association)0.000
GEMINSCpsi-mi:“MI:0915”(physical association)0.000
PRR35INSCpsi-mi:“MI:0915”(physical association)0.000
GPANK1INSCpsi-mi:“MI:0915”(physical association)0.000

BioGRID (29): INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), INSC (Two-hybrid), ZNF587 (Two-hybrid), GPANK1 (Two-hybrid), MGC50722 (Two-hybrid), GPSM2 (Affinity Capture-MS), DNAJC1 (Affinity Capture-MS)

ESM2 similar proteins: A0A8M9QN10, A0JM49, A0JP94, A1EC95, A2AKG8, A2BID5, A9JRI0, B2RYI0, C5J7W8, E7FAW3, E7FGT5, E7FH61, O60287, P42695, P42858, P42859, P49815, P49816, P51111, P51112, Q1MX18, Q3HNM7, Q3U829, Q3UGY8, Q3UHQ6, Q3URQ0, Q571H0, Q5JWR5, Q5R5R2, Q5R6T6, Q5RDK1, Q5TH69, Q5VW36, Q5ZM41, Q61037, Q640K1, Q642P2, Q6A009, Q6AI08, Q6GN08

Diamond homologs: Q1MX18, Q3HNM7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

121 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance103
Likely benign6
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

2795 predictions. Top by Δscore:

VariantEffectΔscore
11:15112578:G:Tdonor_gain1.0000
11:15138711:TCA:Tdonor_gain1.0000
11:15149228:GCG:Gdonor_gain1.0000
11:15175732:T:Aacceptor_gain1.0000
11:15175736:TGCA:Tacceptor_loss1.0000
11:15175737:GCA:Gacceptor_loss1.0000
11:15175738:CAGG:Cacceptor_loss1.0000
11:15175739:A:AGacceptor_gain1.0000
11:15175739:AGGC:Aacceptor_loss1.0000
11:15175740:G:GGacceptor_gain1.0000
11:15176062:G:GTdonor_gain1.0000
11:15176075:G:GTdonor_gain1.0000
11:15176076:A:Tdonor_gain1.0000
11:15178439:G:Tdonor_gain1.0000
11:15178443:TTCAG:Tdonor_loss1.0000
11:15178444:TCAG:Tdonor_loss1.0000
11:15178445:CAGGT:Cdonor_loss1.0000
11:15178446:AGG:Adonor_loss1.0000
11:15178447:GGTC:Gdonor_loss1.0000
11:15178448:G:Cdonor_loss1.0000
11:15178449:T:Gdonor_loss1.0000
11:15190695:TCTTA:Tacceptor_loss1.0000
11:15190696:CTTAG:Cacceptor_loss1.0000
11:15190697:TTAGG:Tacceptor_loss1.0000
11:15190698:TAGGC:Tacceptor_loss1.0000
11:15190699:A:AGacceptor_gain1.0000
11:15190699:A:Cacceptor_loss1.0000
11:15190700:G:Aacceptor_loss1.0000
11:15190700:G:GGacceptor_gain1.0000
11:15190813:AGGTG:Adonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000045599 (11:15130822 A>G), RS1000072156 (11:15143136 A>G), RS1000091999 (11:15135997 C>G), RS1000118304 (11:15142975 A>G), RS1000118770 (11:15222736 A>G), RS1000119498 (11:15226869 A>G,T), RS1000136727 (11:15184149 A>G), RS1000140235 (11:15144917 A>C,G), RS1000157472 (11:15229006 T>C), RS1000188863 (11:15149186 G>A), RS1000193970 (11:15217649 T>G), RS1000194088 (11:15136472 G>A,T), RS1000207381 (11:15182801 T>G), RS1000209815 (11:15178600 GTGA>G), RS1000222003 (11:15269103 T>C)

Disease associations

OMIM: gene MIM:610668 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

9 associations (top):

StudyTraitp-value
GCST001762_863Obesity-related traits6.000000e-06
GCST002013_6Menarche (age at onset)9.000000e-06
GCST002611_2Expressive vocabulary in infants2.000000e-07
GCST006288_115Heel bone mineral density7.000000e-07
GCST006288_29Heel bone mineral density1.000000e-15
GCST006288_726Heel bone mineral density3.000000e-09
GCST006979_620Heel bone mineral density8.000000e-59
GCST006979_621Heel bone mineral density1.000000e-16
GCST006979_622Heel bone mineral density1.000000e-19

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0003939energy intake
EFO:0004703age at menarche
EFO:0006316infant expressive language ability
EFO:0009270heel bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, decreases methylation5
trichostatin Aaffects cotreatment, increases expression3
Vorinostataffects cotreatment, increases expression2
Panobinostataffects cotreatment, increases expression2
Benzo(a)pyrenedecreases methylation, increases expression, increases methylation2
6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium saltaffects cotreatment, increases expression1
bisphenol Aaffects cotreatment, decreases methylation1
sodium arseniteincreases expression1
cupric chlorideincreases expression1
perfluorooctane sulfonic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
abrineincreases expression1
dorsomorphinaffects cotreatment, increases expression1
Fulvestrantaffects cotreatment, decreases methylation, increases methylation1
Arsenicaffects methylation1
Chenodeoxycholic Acidaffects cotreatment, increases expression1
Deoxycholic Acidaffects cotreatment, increases expression1
Glycochenodeoxycholic Acidaffects cotreatment, increases expression1
Glycocholic Acidaffects cotreatment, increases expression1
Glycodeoxycholic Acidaffects cotreatment, increases expression1
Thiramincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideaffects expression1
Cyclosporineincreases expression1
Tungsten Compoundsdecreases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.